David Kerstein

David Kerstein is a highly experienced medical professional currently serving as the Chief Medical Officer at IDRx since March 2024. Previously, David held the role of Chief Medical Officer at Theseus Pharmaceuticals from October 2020 to December 2023, and also served as Senior Vice President and Chief Medical Officer at Anchiano Therapeutics from November 2018 to July 2020. David's expertise includes a significant tenure at Takeda Oncology as Senior Medical Director, focusing on oncology clinical research, where responsibilities included leading lung cancer clinical portfolio strategy and serving as global clinical lead for Brigatinib. David began working in the pharmaceutical industry at ARIAD Pharmaceuticals, Inc., as Senior Medical Director for clinical research, and at Boston Biomedical, Inc., progressing from Manager of Clinical Development to Director of Clinical Development and Regulatory Affairs. Educationally, David earned an MD from Tufts University School of Medicine and a BS in Biology from Tufts University.